497 related articles for article (PubMed ID: 17928470)
1. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
Sigrist MK; Taal MW; Bungay P; McIntyre CW
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
[TBL] [Abstract][Full Text] [Related]
2. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.
Matsuoka M; Iseki K; Tamashiro M; Fujimoto N; Higa N; Touma T; Takishita S
Clin Exp Nephrol; 2004 Mar; 8(1):54-8. PubMed ID: 15067517
[TBL] [Abstract][Full Text] [Related]
3. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
[TBL] [Abstract][Full Text] [Related]
4. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.
Taal MW; Sigrist MK; Fakis A; Fluck RJ; McIntyre CW
Nephron Clin Pract; 2007; 107(4):c177-81. PubMed ID: 17975325
[TBL] [Abstract][Full Text] [Related]
5. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification.
Sigrist MK; Levin A; Er L; McIntyre CW
Nephrol Dial Transplant; 2009 Oct; 24(10):3157-62. PubMed ID: 19491380
[TBL] [Abstract][Full Text] [Related]
6. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
[TBL] [Abstract][Full Text] [Related]
7. Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2010 Jul; 56(1):57-68. PubMed ID: 20347511
[TBL] [Abstract][Full Text] [Related]
8. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4.
Ford ML; Tomlinson LA; Smith ER; Rajkumar C; Holt SG
Nephrol Dial Transplant; 2010 Jun; 25(6):1853-8. PubMed ID: 20075438
[TBL] [Abstract][Full Text] [Related]
9. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
Adragao T; Pires A; Lucas C; Birne R; Magalhaes L; Gonçalves M; Negrao AP
Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
[TBL] [Abstract][Full Text] [Related]
10. Determinants of arterial compliance in patients treated by hemodialysis.
Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
[TBL] [Abstract][Full Text] [Related]
11. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.
Toussaint ND; Kerr PG
Nephrology (Carlton); 2007 Oct; 12(5):500-9. PubMed ID: 17803475
[TBL] [Abstract][Full Text] [Related]
12. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness.
Chesterton LJ; Sigrist MK; Bennett T; Taal MW; McIntyre CW
Nephrol Dial Transplant; 2005 Jun; 20(6):1140-7. PubMed ID: 15827047
[TBL] [Abstract][Full Text] [Related]
13. Does coronary artery calcification in patients with diabetic nephropathy depend on the advancement of renal failure?
Krzanowski M; Kuśnierz-Cabala B; Miarka P; Wójcik K; Stompór T; Sułowicz W
Med Pregl; 2007; 60 Suppl 2():39-42. PubMed ID: 18928155
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of vascular calcification in chronic kidney disease.
Moe SM; Chen NX
Circ Res; 2004 Sep; 95(6):560-7. PubMed ID: 15375022
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.
Garland JS; Holden RM; Groome PA; Lam M; Nolan RL; Morton AR; Pickett W
Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059
[TBL] [Abstract][Full Text] [Related]
16. Vascular calcification and cardiovascular function in chronic kidney disease.
Sigrist M; Bungay P; Taal MW; McIntyre CW
Nephrol Dial Transplant; 2006 Mar; 21(3):707-14. PubMed ID: 16263735
[TBL] [Abstract][Full Text] [Related]
17. Determinants of progressive vascular calcification in haemodialysis patients.
Chertow GM; Raggi P; Chasan-Taber S; Bommer J; Holzer H; Burke SK
Nephrol Dial Transplant; 2004 Jun; 19(6):1489-96. PubMed ID: 15102961
[TBL] [Abstract][Full Text] [Related]
18. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
[TBL] [Abstract][Full Text] [Related]
19. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 levels predict mortality in CKD patients.
David S; John SG; Jefferies HJ; Sigrist MK; Kümpers P; Kielstein JT; Haller H; McIntyre CW
Nephrol Dial Transplant; 2012 May; 27(5):1867-72. PubMed ID: 21976741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
